alphaveAAREYDRUGS₹94.99

Aarey Drugs & Pharmaceuticals Limited

₹ CrorePeersNECLIFE NATCAPSUQ MEDICAMEQ MEDICO BALPHARMA ALPA KREBSBIO HALEOSLABSMcap ₹270 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	14.7	16.2	25.8	25.8
+ Investment Property	1.4	2.1	0.0	0.0
+ Non-current Investments	0.0	0.0	2.1	2.1
+ Long-term Loans	0.7	1.0	6.4	6.4
+ Trade Receivables — Non-current	184.5	0.0	0.0	0.0
+ Other Non-current Financial Assets	5.7	5.7	—	—
Non-current Financial Assets	190.8	6.6	8.5	8.5
Total Non-current Assets	206.9	25.0	34.3	34.3
Current Assets
+ Inventories	34.7	45.5	41.5	41.5
+ Trade Receivables	0.0	129.6	129.7	129.7
+ Cash & Cash Equivalents	1.6	1.5	1.4	1.4
+ Short-term Loans	15.5	29.9	20.6	20.6
+ Other Current Financial Assets	46.3	1.8	69.7	69.7
Current Financial Assets	63.4	162.8	221.4	221.4
+ Other Current Assets	0.0	5.0	—	—
Total Current Assets	98.1	213.3	262.9	262.9
Total Assets	305.0	238.3	297.2	297.2
Equity
+ Equity Share Capital	28.1	28.1	28.5	28.5
+ Other Equity / Reserves	104.7	110.4	122.0	122.0
Equity — Owners of Parent	132.8	138.5	150.4	150.4
Total Equity	132.8	138.5	150.4	150.4
Liabilities
+ Borrowings — Non-current	3.2	2.0	1.0	1.0
Non-current Financial Liabilities	3.2	2.0	1.0	1.0
+ Deferred Tax Liabilities	0.7	0.9	0.8	0.8
Non-current Liabilities	4.0	2.9	1.7	1.7
+ Borrowings — Current	28.1	32.9	49.0	49.0
+ Trade Payables	128.9	54.1	81.6	81.6
+ Other Current Financial Liab	0.0	0.0	10.8	10.8
Current Financial Liabilities	157.1	87.0	141.4	141.4
+ Provisions — Current	4.4	2.7	2.1	2.1
+ Current Tax Liabilities	1.3	1.4	1.6	1.6
+ Other Current Liabilities	5.4	5.7	—	—
Current Liabilities	168.2	96.9	145.1	145.1
Total Liabilities	172.2	99.8	146.8	146.8
Total Equity & Liabilities	305.0	238.3	297.2	297.2
Trade Payables — MSME split
+ Dues to Other Creditors — Current	—	54.1	81.6	81.6
Regulatory Disclosures — filed alongside, not part of the B/S
+ Original Allocation	—	—	—	31.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.